48,448
edits
Difference between revisions of "SMARCB1"
Jump to navigation
Jump to search
no edit summary
| Line 27: | Line 27: | ||
* Up to 30% of [[synovial sarcoma]].<ref>{{Cite journal | last1 = Mularz | first1 = K. | last2 = Harazin-Lechowska | first2 = A. | last3 = Ambicka | first3 = A. | last4 = Kruczak | first4 = A. | last5 = Rozmus-Piętoń | first5 = M. | last6 = Marchińska-Osika | first6 = U. | last7 = Swiątkiewicz | first7 = I. | last8 = Król | first8 = M. | last9 = Pabis | first9 = D. | title = Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma. | journal = Pol J Pathol | volume = 63 | issue = 3 | pages = 179-83 | month = Nov | year = 2012 | doi = | PMID = 23161234 }}</ref> | * Up to 30% of [[synovial sarcoma]].<ref>{{Cite journal | last1 = Mularz | first1 = K. | last2 = Harazin-Lechowska | first2 = A. | last3 = Ambicka | first3 = A. | last4 = Kruczak | first4 = A. | last5 = Rozmus-Piętoń | first5 = M. | last6 = Marchińska-Osika | first6 = U. | last7 = Swiątkiewicz | first7 = I. | last8 = Król | first8 = M. | last9 = Pabis | first9 = D. | title = Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma. | journal = Pol J Pathol | volume = 63 | issue = 3 | pages = 179-83 | month = Nov | year = 2012 | doi = | PMID = 23161234 }}</ref> | ||
* [[Renal medullary carcinoma]]. | * [[Renal medullary carcinoma]]. | ||
* Renal carcinoma (not ''rhabdoid tumour'' and not ''medullary carcinoma'').<ref>{{cite journal |authors=Agaimy A, Hartmann A |title=[SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts] |language=German |journal=Pathologe |volume=42 |issue=6 |pages=571–577 |date=November 2021 |pmid=34609565 |doi=10.1007/s00292-021-00985-y |url=}}</ref> | |||
* Rhabdoid carcinoma of gastrointestinal tract.<ref name=pmid24503755>{{cite journal |authors=Agaimy A, Rau TT, Hartmann A, Stoehr R |title=SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review |journal=Am J Surg Pathol |volume=38 |issue=7 |pages=910–20 |date=July 2014 |pmid=24503755 |doi=10.1097/PAS.0000000000000173 |url=}}</ref> | * Rhabdoid carcinoma of gastrointestinal tract.<ref name=pmid24503755>{{cite journal |authors=Agaimy A, Rau TT, Hartmann A, Stoehr R |title=SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review |journal=Am J Surg Pathol |volume=38 |issue=7 |pages=910–20 |date=July 2014 |pmid=24503755 |doi=10.1097/PAS.0000000000000173 |url=}}</ref> | ||